Mainz Biomed N.V (MYNZ) Cash & Current Investments: 2020-2025
Historic Cash & Current Investments for Mainz Biomed N.V (MYNZ) over the last 2 years, with Jun 2025 value amounting to $6.2 million.
- Mainz Biomed N.V's Cash & Current Investments fell 11.81% to $6.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $26.6 million, marking a year-over-year decrease of 61.24%. This contributed to the annual value of $6.2 million for FY2024, which is 11.81% down from last year.
- Mainz Biomed N.V's Cash & Current Investments amounted to $6.2 million in Q2 2025, which was down 0.00% from $6.2 million recorded in Q4 2024.
- Mainz Biomed N.V's Cash & Current Investments' 5-year high stood at $52.0 million during Q2 2022, with a 5-year trough of $6.2 million in Q4 2024.
- Its 3-year average for Cash & Current Investments is $15.6 million, with a median of $7.1 million in 2024.
- Per our database at Business Quant, Mainz Biomed N.V's Cash & Current Investments spiked by 7,020.57% in 2021 and then tumbled by 74.79% in 2024.
- Quarterly analysis of 5 years shows Mainz Biomed N.V's Cash & Current Investments stood at $8.7 million in 2021, then spiked by 96.41% to $17.1 million in 2022, then crashed by 58.75% to $7.1 million in 2023, then declined by 11.81% to $6.2 million in 2024, then fell by 11.81% to $6.2 million in 2025.
- Its Cash & Current Investments stands at $6.2 million for Q2 2025, versus $6.2 million for Q4 2024 and $7.1 million for Q2 2024.